威高骨科收盘上涨4.26%，滚动市盈率47.24倍，总市值113.68亿元

Group 1 - The core viewpoint of the articles highlights the performance and market position of Weigao Orthopedics, noting its stock price increase and current valuation metrics [1][2] - As of July 24, Weigao Orthopedics closed at 28.42 yuan, with a 4.26% increase, and a rolling PE ratio of 47.24, marking a new low in 76 days, with a total market capitalization of 11.368 billion yuan [1] - The average PE ratio for the medical device industry is 54.56, with a median of 37.54, placing Weigao Orthopedics at the 85th position in the industry ranking [1][2] Group 2 - The company specializes in a wide range of orthopedic products, including spinal, trauma, joint, sports medicine, bone repair materials, tissue repair, and surgical instruments, making it a leading domestic enterprise in the orthopedic sector [1] - Weigao Orthopedics holds a total of 371 patents, including 86 invention patents and 266 utility model patents [1] - In the first quarter of 2025, the company reported a revenue of 290 million yuan, a year-on-year decrease of 16.59%, while net profit reached 51.789 million yuan, reflecting a year-on-year increase of 48.37%, with a gross profit margin of 63.68% [1]